133 related articles for article (PubMed ID: 4920305)
1. Enzymatic aspects of sphingolipid degradation.
Gatt S
Chem Phys Lipids; 1970 Oct; 5(1):235-49. PubMed ID: 4920305
[No Abstract] [Full Text] [Related]
2. Enzymic hydrolysis of glycolipids and phospholipids.
Gatt S
Biochem J; 1970 Apr; 117(2):4P-5P. PubMed ID: 5420071
[No Abstract] [Full Text] [Related]
3. Hexosaminidase activities in a case of systemic GM2 gangliosidosis of late infantile type.
Schneck L; Friedland J; Pourfar M; Saifer A; Volk BW
Proc Soc Exp Biol Med; 1970 Mar; 133(3):997-8. PubMed ID: 5435594
[No Abstract] [Full Text] [Related]
4. [Enzymatic diagnosis of glycolipidosis].
Zambotti V; Di Donato S; Rimoldi M; Tettamanti G
Quad Sclavo Diagn; 1972 Mar; 8(1):183-98. PubMed ID: 4351703
[No Abstract] [Full Text] [Related]
5. Some aspects of the cellular biochemistry of lysosomal and related glycosidases.
Touster O
Mol Cell Biochem; 1973 Dec; 2(2):169-77. PubMed ID: 4594433
[No Abstract] [Full Text] [Related]
6. Demonstration of an alteration of ganglioside metabolism in Tay-Sachs disease.
Kolodny EH; Brady RO; Volk BW
Biochem Biophys Res Commun; 1969 Oct; 37(3):526-31. PubMed ID: 5388728
[No Abstract] [Full Text] [Related]
7. Lysosomes and mucopolysaccharidoses.
Hers HG; van Hoof F
Biochem J; 1969 Dec; 115(5):34P-36P. PubMed ID: 4243352
[No Abstract] [Full Text] [Related]
8. [Enzyme defects in lipid metabolism].
Braunsteiner H; Sailer S; Sandhofer F
Wien Klin Wochenschr; 1970 Oct; 82(42):724-7. PubMed ID: 4097155
[No Abstract] [Full Text] [Related]
9. Enzyme alterations and lipid storage in three variants of Tay-Sachs disease.
Sandhoff K; Harzer K; Wässle W; Jatzkewitz H
J Neurochem; 1971 Dec; 18(12):2469-89. PubMed ID: 5135907
[No Abstract] [Full Text] [Related]
10. Requirement of an activator for the hydrolysis of sphingoglycolipids by glycosidases of human liver.
Li SC; Wan CC; Mazzotta MY; Li YT
Carbohydr Res; 1974 May; 34(1):189-93. PubMed ID: 4835697
[No Abstract] [Full Text] [Related]
11. The adnormal biochemistry of inherited disorders of lipid metabolism.
Brady RO
Fed Proc; 1973 Jun; 32(6):1660-7. PubMed ID: 4351098
[No Abstract] [Full Text] [Related]
12. Metabolic diseases: more clues from enzymes.
Nature; 1970 May; 226(5246):596. PubMed ID: 5444922
[No Abstract] [Full Text] [Related]
13. Abnormal distribution of lysosomal isoenzymes in mucopolysaccharidosis.
Kint JA; Dacremont G; Carton D
Arch Int Physiol Biochim; 1972 Dec; 80(5):972-3. PubMed ID: 4127090
[No Abstract] [Full Text] [Related]
14. Tay-sachs disease.
Brady RO
N Engl J Med; 1969 Nov; 281(22):1243-4. PubMed ID: 5347842
[No Abstract] [Full Text] [Related]
15. Biochemical studies in cat and human gangliosidosis.
Handa S; Yamakawa T
J Neurochem; 1971 Jul; 18(7):1275-80. PubMed ID: 5118883
[No Abstract] [Full Text] [Related]
16. Ceramidase deficiency in Farber's disease (lipogranulomatosis).
Sugita M; Dulaney JT; Moser HW
Science; 1972 Dec; 178(4065):1100-2. PubMed ID: 4678225
[TBL] [Abstract][Full Text] [Related]
17. Tissue acid hydrolase activities in Gaucher's disease.
Ockerman PA; Köhlin P
Scand J Clin Lab Invest; 1968; 22(1):62-4. PubMed ID: 5706652
[No Abstract] [Full Text] [Related]
18. Hydrolysis of ceramide lactoside and ceramide glucoside by glycosidases from brain.
Papavassiliou J
Isr J Med Sci; 1965 Jul; 1(4):624-7. PubMed ID: 5842275
[No Abstract] [Full Text] [Related]
19. Gangliosides, glycosidases, and sialidase in the brain and eyes of developing chickens.
Schengrund CL; Rosenberg A
Biochemistry; 1971 Jun; 10(12):2424-8. PubMed ID: 5115000
[No Abstract] [Full Text] [Related]
20. Ganglioside storage diseases.
O'Brien JS; Okada S; Ho MW; Fillerup DL; Veath ML; Adams K
Fed Proc; 1971; 30(3):956-69. PubMed ID: 4252532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
